Reports Summarize Gastric Cancer Research from Fudan University Shanghai Cancer Center (A prospective phase II single-arm study and predictive factor analysis of irinotecan as third-line treatment in patients with metastatic gastric cancer)

Source :: Obesity, Fitness & Wellness Week. March 23, 2024, 1914
Publication Year :: 2024
Abstract: 2024 MAR 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in gastric cancer. According to news originating from [...]

Subjects :: Antineoplastic agents -- Dosage and administration
Metastasis -- Diagnosis -- Care and treatment
Stomach cancer -- Development and progression -- Care and treatment
Chemotherapy -- Patient outcomes
Cancer -- Chemotherapy
Antimitotic agents -- Dosage and administration
Health

Tools